How is risk stratification used in making treatment decisions? What is risk-adaptive therapy?

How is risk stratification used in making treatment decisions? What is risk-adaptive therapy?
Is response the same as remission?
BETA - How are liver enzymes monitored and managed? What therapies have been known to affect liver values?
BETA - What is thrombocytopenia? How is thrombocytopenia monitored? How is Thrombocytopenia managed?
Do the benefits of a BMT outweigh the risks?
What factors should be considered when stratifying a patient as high risk or standard risk?
What is considered high risk multiple myeloma (HRMM)? Is this a standardized definition?
What does it mean to be MRD positive? What does this mean for my long term outcomes?
At what time points in the myeloma journey should risk stratification occur? Can risk status change?
BETA - Should myeloma patients avoid sugar? Does sugar cause cancer?
BETA - Can diet cure myeloma?